| pubmed-article:19805692 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:19805692 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
| pubmed-article:19805692 | lifeskim:mentions | umls-concept:C0376358 | lld:lifeskim |
| pubmed-article:19805692 | lifeskim:mentions | umls-concept:C0008976 | lld:lifeskim |
| pubmed-article:19805692 | lifeskim:mentions | umls-concept:C0032952 | lld:lifeskim |
| pubmed-article:19805692 | lifeskim:mentions | umls-concept:C1514457 | lld:lifeskim |
| pubmed-article:19805692 | lifeskim:mentions | umls-concept:C1420342 | lld:lifeskim |
| pubmed-article:19805692 | lifeskim:mentions | umls-concept:C0282461 | lld:lifeskim |
| pubmed-article:19805692 | lifeskim:mentions | umls-concept:C1696465 | lld:lifeskim |
| pubmed-article:19805692 | lifeskim:mentions | umls-concept:C1142934 | lld:lifeskim |
| pubmed-article:19805692 | pubmed:issue | 32 | lld:pubmed |
| pubmed-article:19805692 | pubmed:dateCreated | 2009-11-9 | lld:pubmed |
| pubmed-article:19805692 | pubmed:abstractText | This multinational, double-blind, randomized, placebo-controlled, phase III trial assessed the efficacy and tolerability of the oral platinum analog satraplatin in patients with metastatic castrate-refractory prostate cancer (CRPC) experiencing progression after one prior chemotherapy regimen. | lld:pubmed |
| pubmed-article:19805692 | pubmed:language | eng | lld:pubmed |
| pubmed-article:19805692 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19805692 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:19805692 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19805692 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19805692 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19805692 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:19805692 | pubmed:month | Nov | lld:pubmed |
| pubmed-article:19805692 | pubmed:issn | 1527-7755 | lld:pubmed |
| pubmed-article:19805692 | pubmed:author | pubmed-author:HarperPeterP | lld:pubmed |
| pubmed-article:19805692 | pubmed:author | pubmed-author:SternbergCora... | lld:pubmed |
| pubmed-article:19805692 | pubmed:author | pubmed-author:WitjesJ... | lld:pubmed |
| pubmed-article:19805692 | pubmed:author | pubmed-author:FerreroJean-M... | lld:pubmed |
| pubmed-article:19805692 | pubmed:author | pubmed-author:CalabròFabioF | lld:pubmed |
| pubmed-article:19805692 | pubmed:author | pubmed-author:EymardJean-Ch... | lld:pubmed |
| pubmed-article:19805692 | pubmed:author | pubmed-author:WirthManfredM | lld:pubmed |
| pubmed-article:19805692 | pubmed:author | pubmed-author:SartorOliverO | lld:pubmed |
| pubmed-article:19805692 | pubmed:author | pubmed-author:PetrylakDanie... | lld:pubmed |
| pubmed-article:19805692 | pubmed:author | pubmed-author:BerryWilliamW | lld:pubmed |
| pubmed-article:19805692 | pubmed:author | pubmed-author:DemkowTomaszT | lld:pubmed |
| pubmed-article:19805692 | pubmed:author | pubmed-author:BodrogiIstvan... | lld:pubmed |
| pubmed-article:19805692 | pubmed:author | pubmed-author:JamesNicholas... | lld:pubmed |
| pubmed-article:19805692 | pubmed:author | pubmed-author:GeorgeMartine... | lld:pubmed |
| pubmed-article:19805692 | pubmed:author | pubmed-author:FalconSilviaS | lld:pubmed |
| pubmed-article:19805692 | pubmed:author | pubmed-author:PetroneMichae... | lld:pubmed |
| pubmed-article:19805692 | pubmed:author | pubmed-author:McKearnThomas... | lld:pubmed |
| pubmed-article:19805692 | pubmed:author | pubmed-author:NoursalehiMoj... | lld:pubmed |
| pubmed-article:19805692 | pubmed:author | pubmed-author:RozencweigMar... | lld:pubmed |
| pubmed-article:19805692 | pubmed:issnType | Electronic | lld:pubmed |
| pubmed-article:19805692 | pubmed:day | 10 | lld:pubmed |
| pubmed-article:19805692 | pubmed:volume | 27 | lld:pubmed |
| pubmed-article:19805692 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:19805692 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:19805692 | pubmed:pagination | 5431-8 | lld:pubmed |
| pubmed-article:19805692 | pubmed:meshHeading | pubmed-meshheading:19805692... | lld:pubmed |
| pubmed-article:19805692 | pubmed:meshHeading | pubmed-meshheading:19805692... | lld:pubmed |
| pubmed-article:19805692 | pubmed:meshHeading | pubmed-meshheading:19805692... | lld:pubmed |
| pubmed-article:19805692 | pubmed:meshHeading | pubmed-meshheading:19805692... | lld:pubmed |
| pubmed-article:19805692 | pubmed:meshHeading | pubmed-meshheading:19805692... | lld:pubmed |
| pubmed-article:19805692 | pubmed:meshHeading | pubmed-meshheading:19805692... | lld:pubmed |
| pubmed-article:19805692 | pubmed:meshHeading | pubmed-meshheading:19805692... | lld:pubmed |
| pubmed-article:19805692 | pubmed:meshHeading | pubmed-meshheading:19805692... | lld:pubmed |
| pubmed-article:19805692 | pubmed:meshHeading | pubmed-meshheading:19805692... | lld:pubmed |
| pubmed-article:19805692 | pubmed:meshHeading | pubmed-meshheading:19805692... | lld:pubmed |
| pubmed-article:19805692 | pubmed:meshHeading | pubmed-meshheading:19805692... | lld:pubmed |
| pubmed-article:19805692 | pubmed:meshHeading | pubmed-meshheading:19805692... | lld:pubmed |
| pubmed-article:19805692 | pubmed:meshHeading | pubmed-meshheading:19805692... | lld:pubmed |
| pubmed-article:19805692 | pubmed:meshHeading | pubmed-meshheading:19805692... | lld:pubmed |
| pubmed-article:19805692 | pubmed:meshHeading | pubmed-meshheading:19805692... | lld:pubmed |
| pubmed-article:19805692 | pubmed:meshHeading | pubmed-meshheading:19805692... | lld:pubmed |
| pubmed-article:19805692 | pubmed:meshHeading | pubmed-meshheading:19805692... | lld:pubmed |
| pubmed-article:19805692 | pubmed:meshHeading | pubmed-meshheading:19805692... | lld:pubmed |
| pubmed-article:19805692 | pubmed:meshHeading | pubmed-meshheading:19805692... | lld:pubmed |
| pubmed-article:19805692 | pubmed:meshHeading | pubmed-meshheading:19805692... | lld:pubmed |
| pubmed-article:19805692 | pubmed:meshHeading | pubmed-meshheading:19805692... | lld:pubmed |
| pubmed-article:19805692 | pubmed:meshHeading | pubmed-meshheading:19805692... | lld:pubmed |
| pubmed-article:19805692 | pubmed:meshHeading | pubmed-meshheading:19805692... | lld:pubmed |
| pubmed-article:19805692 | pubmed:year | 2009 | lld:pubmed |
| pubmed-article:19805692 | pubmed:articleTitle | Multinational, double-blind, phase III study of prednisone and either satraplatin or placebo in patients with castrate-refractory prostate cancer progressing after prior chemotherapy: the SPARC trial. | lld:pubmed |
| pubmed-article:19805692 | pubmed:affiliation | San Camillo and Forlanini Hospitals, Rome, Italy. cstern@mclink.it | lld:pubmed |
| pubmed-article:19805692 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:19805692 | pubmed:publicationType | Randomized Controlled Trial | lld:pubmed |
| pubmed-article:19805692 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| pubmed-article:19805692 | pubmed:publicationType | Multicenter Study | lld:pubmed |
| pubmed-article:19805692 | pubmed:publicationType | Clinical Trial, Phase III | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:19805692 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:19805692 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:19805692 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:19805692 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:19805692 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:19805692 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:19805692 | lld:pubmed |
